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Abstract
Interleukin (IL)-4, a pleiotropic cytokine involved in many glomerular diseases, is regulated positively by membrane-
bound IL-4R (mIL-4R) and negatively by soluble IL-4R (sIL-4R). Because natural sIL-4R has been documented only in
mice, we undertook this study in rats to determine whether they, too, express sIL-4R, particularly in kidney cells. A pair of
IL-4R primers was designed for this purpose and used in the polymerase chain reaction. As a result, sIL-4R was found not
only in rats spleen cells but also in their glomerular epithelial cells (GEC). Sequence analysis revealed that the mRNA of rat
sIL-4R has a 75-bp insert sequence. This insert generated a termination TGA codon upstream from the transmembrane
region, resulting in formation of the sIL-4R. Subsequent screening of the kidney cDNA library enabled us to obtain the
whole 3605-bp cDNA of sIL-4R; the full-length 3530-bp mIL-4R cDNA was also identified as a much longer sequence than
previously published. Among the total 39 clones positive for IL-4R, two were confirmed as sIL-4R, and 37 clones were
positive for mIL-4R. Next, the translated portion of sIL-4R cDNA was constructed into an expression vector, enabling us to
obtain a recombinant sIL4R-myc fusion protein. By using this recombinant sIL-4R, we proved that sIL-4R can antagonize
the IL-4-induced proliferation of spleen cells. Present study demonstrated that sIL-4R is expressed in kidney cells and
antagonistically functional. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Interleukin (IL)-4, produced mainly by activated
T cells, has a broad spectrum of biological activities.
This cytokine regulates such aspects of lymphocyte
function as induction, activation and di¡erentiation
of B cells, suppression of B-cell apoptosis, promotion
of precursor T helper cell di¡erentiation into mature
Th2 cells and inhibition of some proin£ammatory
cytokines production [1^4]. In addition to its immu-
nomodulatory functions, IL-4 can also mediate mur-
ine pulmonary and human dermal ¢broblast prolif-
eration, cytokine synthesis and extracellular matrix
production [5,6]. Moreover, recombinant rat IL-4
was found to enhance epithelial cell proliferation [7].
Up to now, evidence that IL-4 is involved in renal
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disease comes from several sources. In vivo, in¢ltra-
tion of IL-4-producing T cells is a common patho-
logical feature in the renal diseases of humans and
rats [8^19]. In vitro, IL-4 has stimulated synthesis of
the extracellular matrix, caused the release of cyto-
kines such as IL-6, IL-8 and MCP-1 by glomerular
mesangial cells and glomerular epithelial cells (GEC)
[20,21]. Moreover, IL-4 enhances the expression of
vascular cell adhesion molecule-1 (VCAM-1) by
GEC [22]. IL-4 also inhibits of proliferation of hu-
man mesangial cells [23].
IL-4 manifests its biological e¡ects by binding to
speci¢c receptors on the cell surface. Mice have two
kinds of IL-4 receptors: membrane bound IL-4R
(mIL-4R) and soluble IL-4R (sIL-4R). Mature mur-
ine mIL-4R is a 140 kDa transmembrane glycopro-
tein containing extracellular, transmembrane and cy-
toplasmic domains. In contrast, sIL-4R has only the
extracellular portion and completely lacks the trans-
membrane and cytoplasmic domains [1]. These two
forms are encoded by distinct mRNAs, both derived
from the same gene [1]. In sIL-4R, a 114-bp insert
introduces a termination TGA codon that ends the
open reading frame upstream of the predicted trans-
membrane region, resulting in a truncated form of
the receptor [1]. The important similarity, though, is
that mIL-4R and sIL-4R have the same a⁄nity to
IL-4; mIL-4R can combine with IL-4 and transmit
signals across the plasma membrane, thus initiating
the biological activities of IL-4 [24]. In contrast, sIL-
4R retains high ligand-binding activity and acts as a
competitive inhibitor of IL-4 binding to membrane
receptors, thereby regulating the biological activity of
IL-4 [3,25^29]. Until now, sIL-4R has been found
only in mice, although mIL-4R cDNA has been
documented in rats [30]. Even so, some researchers
have concluded that the expression of sIL-4R is lim-
ited to murine species alone [31].
To resolve this issue, we designed a pair of IL-4R
primers and conducted the polymerase chain reaction
(PCR). Use of this technology identi¢ed sIL-4R in
rats. We then screened the kidney cDNA library and
obtained the entire cDNA of sIL-4R. This recombi-
nant sIL-4R was then used to investigate the recep-
tors e¡ect on cell proliferation induced by IL-4 in
spleen cells. The results con¢rmed that sIL-4R is
capable of speci¢cally neutralizing the biological ef-
fects of IL-4. This is the ¢rst report of sIL-4R in the
rat and of sIL-4R expression in renal cells.
2. Materials and methods
2.1. Cells
An established cell line of rat GEC was used and
cultured in a 1:1 fresh mixture of K1 medium and
3T3 ¢broblast-conditioned medium. K1 medium
contains Ham F-12 (Life Technologies, Grand Is-
land, NY), Dulbecco’s modi¢ed Eagle’s medium
(DMEM), Nu Serum (Collaborative Research, Bed-
fold, MA), L-glutamine, ITS (insulin, transferrin, se-
lenium), Hepes and antibiotics.
Wistar rat MC, NRK (normal rat kidney ¢bro-
blast), Swiss mouse 3T3 ¢broblast and COS-7 mon-
key kidney cells were obtained from American Type
Culture Collection (ATCC) and maintained in
DMEM supplemented with 10% heat-inactivated fe-
tal bovine serum, L-glutamine, L-arginine, L-aspara-
gine, sodium pyruvate and Hepes.
2.2. Animals and tissue preparation
Male Wistar rats, 5 weeks of age, were purchased
from SLC Co., Japan and maintained in our animal
facility. Specimens of various organs were obtained
and snap-frozen in liquid nitrogen, then stored at
370‡C for further use.
2.3. Isolation of total RNA
Total RNA was isolated from cultured cells and
tissues using ISOGEN (Nippon Gene, Japan) as rec-
ommended by the manufacturer. The precipitated
RNAs were dissolved in diethyl pyrocarbonate
(DEPC)-treated water containing 0.5% sodium do-
decyl sulfate (SDS). Quanti¢cation was done by
spectrophotometer.
2.4. Reverse transcription of RNA
cDNA synthesis was carried out in 100 Wl of a
reaction mixture containing 2 Wg of total RNA, 20
Wl 5URT bu¡er, 10 Wl 2.5 mM dNTPs, 1 Wl 20 WM
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Oligo dT15 Primer, 1 Wl ribonuclease inhibitor. After
heating at 68‡C for 5 min then icing, 1 Wl of Moloney
murine leukemia virus reverse transcriptase (RT) was
added and incubated at 42‡C for 45 min. This was
followed by heat-inactivation of the RT at 68‡C for
5 min.
2.5. PCR ampli¢cation of IL-4R mRNA
PCR ampli¢cation was performed in a 25 Wl reac-
tion containing 1 Wl of reverse-transcribed RNA,
2.5 Wl 10UPCR bu¡er (Toyobo), 1.5 Wl 25 mM
MgCl2, 1 Wl 2.5 mM dNTP, 1 Wl 25 WM primer
and 1 unit rTaq DNA polymerase (Boehringer
Mannheim, Germany). Samples were overlaid with
mineral oil and heated at 94‡C for 3 min, followed
by 30 cycles (denaturation at 94‡C for 1 min, anneal-
ing at 60‡C for 1 min and extension at 72‡C for
2 min) and at 72‡C for 5 min. The PCR products
were visualized on a 2% agarose gel by ethidium
bromide staining. The primers used in this study
were as follows. (1) for IL-4R: 5P-AGT CAA CAC
CCT AAC ATC AGG G-3P (sense) and 5P-GGC
CTC AAA CAG CTC CAT ACA G-5P (antisense).
Two bands were obtained, the 547-bp band repre-
senting a mIL-4R message, and the 622-bp band
indicating a sIL-4R message. (2) For the rat insert
sequence (RIS) of soluble IL-4 receptor: 5P-CAA
ATA ATG TCA ATC TG-3P (sense) and 5P-CAG
CTC CAC TGC TCT GT-3P spanning a 75-bp frag-
ment (antisense). (3) For actin, used as control: 5P-
ATG TAC GTA GCC ATC CAG GCT-3P (sense)
and 5P-ATT GCC GAT AGT GAT GAC-3P span-
ning a 363-bp fragment (antisense).
2.6. Sequencing of the PCR products
The PCR products were electrophoresed and the
two bands were puri¢ed with a DNA Puri¢cation kit
(Bio-Rad Laboratories, USA). The puri¢ed frag-
ments were cloned into a TA vector according to
the standard protocols using a TA Cloning kit (In-
vitrogen, USA) In brief, 2 Wl puri¢ed PCR products,
1 Wl 10-fold ligase bu¡er, 2 Wl TA Vector, 1 Wl T4
ligase and 4 Wl sterile water were allowed to incubate
at 14‡C overnight.
Recombinant plasmids were transfected to compe-
tent cells, then ampli¢ed and identi¢ed by EcoRI
restriction digestion. Nucleotide sequence analysis
was conducted by £uorescent dye primers (T7 and
reverse primers) using Thermo Sequenase £uores-
cent-labeled primer cycle sequencing kit with 7-dea-
za-dGTP (Amersham Life Science, UK) according to
the manufacturer’s instructions. Automatic DNA se-
quencing was performed with DNA Sequencer. To
exclude PCR artifacts, all IL-4R sequences were de-
termined in three separate clones.
2.7. Isolation of cDNA and determination of the
cDNA sequence
The cDNA library was constructed in the Vgt10
vector with mRNA from Sprague^Dawley rat kid-
ney. The library was screened ¢rst with the PCR
product of IL-4R (622 bp) and then with RIS (75
bp) as mentioned above. The probes were labeled
by a random primer method using [K-32P]dCTP
and the Klenow enzyme (Boehringer Mannheim).
The hybridization solution was 50% formamide,
5USSC (1USSC: 0.15 M sodium chloride, 0.015
M sodium citrate), 8UDenhardt’s solution (1UDen-
hardt’s solution: 0.02% Ficoll, 0.02% polyvinyl
pyrolidone, 0.02% bovine serum albumin), 50 mM
phosphate bu¡er (pH 6.5), and 250 Wg/ml heat-dena-
tured herring sperm DNA. The ¢lters were hy-
bridized with labeled probes overnight at 42‡C and
washed twice in 2USSC/0.1% SDS at room temper-
ature for 5 min, and subsequently washed twice in
0.1USSC/0.1% SDS at 65‡C for 20 min, then ex-
posed to Kodak XAR ¢lm with intensifying screen
at 370‡C. After the third screening, single positive
clones were selected and NotI/SalI inserts were
cloned into pBluescriptSK+ vector (Stratagene,
USA). Since the insert cDNA is about 4 kbp, small
fragments were obtained by digestion with several
special restriction enzymes, then subcloned into
pBluescriptSK again. The DNA sequence was de-
termined in both directions by the dideoxy chain
termination procedure using £uorescence-labeled T7
and reverse primers as cited above. DNA sequence
assembly and comparison were carried out by use of
the GENEYTX-MAC program.
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2.8. Construction and expression of sIL-4R fusion
protein
The translation part of sIL4R cDNA was trimmed
between nt 158 and nt 865 with synthetic BamHI and
EcoRV adapter by PCR from the full-length sIL-4R
cDNA (pBSSK/RS36). The upstream sense primer
containing the BamHI restriction endonuclease site
is 5P-GGG GAT CCA GGC ACC TTT GTG T-3P
and the downstream antisense primer containing the
EcoRV site is 5P-GGA TAT CAG ATT GAC ATT
ATT TGG-3P. The ampli¢ed product was digested
with BamHI/EcoRV and subcloned into the mamma-
lian expression vector pcDNA3.1C (Invitrogen, The
Netherlands) to generate pcDNA3.1C/sIL4R and
subsequently con¢rmed by sequence analysis.
The constructed pcDNA3.1C/sIL4R was used to
transfect a subcon£uent layer of COS-7 cells by
TfxTM-20 Reagent for the Transfection of Eukary-
otic Cells kit (Promega, USA) according to the rec-
ommended instructions. The cells were then grown in
culture to permit transient expression of the inserted
sequence. pcDNA3.1C vector alone and pcDNA3.1-
LacZ (Invitrogen) were also used as controls. After
3 days, supernatants were harvested and the re-
combinant fusion protein were puri¢ed by Xpress
System ProBond Resin (Invitrogen) according to
the recommended instructions. The recombinant
fusion proteins were dialyzed with PBS and concen-
trated by molecular cut ¢lter, then quantitated.
2.9. Cell proliferation assays
A splenocyte proliferation assay was used to deter-
mine IL-4 bioactivity [32]. Spleens were aseptically
removed from Wistar rats, and the cells were isolated
and ¢ltered through Sephadex G-10 (Pharmacia,
Sweden) to remove adherent cells as previously de-
scribed [33]. Splenocytes (5U104 cells/well) were cul-
tured in triplicate in 96-well microtiter plates in 10%
FCS/DMEM with 10 nM PMA and 50 WM 2-ME.
These cells were treated with 10 ng/ml recombinant
rat IL-4 (R p D Systems, USA) in the presence of
various concentrations of recombinant rat sIL-4R-
myc or recombinant LacZ-myc and cultured at
37‡C. [3H]Thymidine (1 WCi/well) was added during
the last 6 h of a 24-h incubation period, after which
the cells were harvested onto glass-¢ber ¢lters and
examined for thymidine uptake by liquid scintillation
counter.
3. Results
3.1. Expression of sIL-4 receptors in GEC
To explore whether natural sIL-4R is expressed in
rats, we devised a pair of primers spanning the re-
ceptor of extracellular and intracellular domains con-
taining the transmembrane region. The primer se-
quences were deduced from mouse IL-4R primers
[5] and the rat IL-4R cDNA sequence (EMBL acces-
sion number X69903). We assumed that if the rat
system includes sIL-4R with an inserted sequence
like that in the mouse, PCR would amplify bands
of sIL-4R and also mIL-4R. On that premise, the
RT^PCR was conducted on cultured rat MC,
GEC, NRK and normal kidney tissue. Spleen cells
and COS-7 cells were also used as positive and neg-
ative controls respectively. According to the results
of PCR, GEC and normal kidney tissues had two
bands (Fig. 1). However, the large band was very
faint in were also present in the control spleen cells,
but none was apparent in COS-7 cells. Negative con-
trols without template cDNA or reverse transcriptase
were also included but contained no bands (not
shown). Ampli¢cation of the housekeeping gene, ac-
tin, was used as a control for RNA integrity and
PCR. The expression of actin was equally expressed
Fig. 1. RT^PCR analysis of rat IL-4R mRNA expression. Sam-
ples were mesangial cells (lane 1), GEC (lane 2), NRK (lane 3),
kidney tissue (lane 4), spleen cells (lane 5), and COS-7 cells
(lane 6). The band at 622 bp corresponds to the sIL-4R mes-
sage and the band at 547 bp stands for mIL-4R. The house-
keeping gene, actin (363 bp), was also ampli¢ed as a positive
control for intact RNA and e⁄ciency of RT^PCR.
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in each sample (Fig. 1). These results denoted the
existence of sIL-4R in the rat.
3.2. Sequence analysis of rat PCR products
To con¢rm that the PCR products were rat IL-4R,
the two bands ampli¢ed in glomerular epithelial cells
were isolated and puri¢ed separately, then subcloned
into TA cloning vectors. When the sequences were
determined and compared with the published rat IL-
4 receptor cDNA sequence, one band that had been
considered as a membrane-bound receptor was com-
pletely identical to the predicted, published sequence,
showing that the primer-ampli¢ed fragment was rat
IL-4R. Meanwhile, another band thought to repre-
sent the soluble receptor had an exceptionally short
sequence that di¡ered from the long one only by a
75-bp insert (black boxed in Fig. 2). The nucleic acid
sequence of inserted fragment varied from that of
mouse [1] by 6 amino acids and the termination
site. This termination site induced formation of
sIL-4R.
3.3. Isolation of full-length rat IL-4R cDNA
Since RT^PCR showed, and sequencing con-
¢rmed, that rats express sIL-4R, a rat kidney
cDNA library was screened. For the ¢rst screening,
we used the 622-bp IL-4R PCR product as a probe
that recognized both sIL-4R and mIL-4R. Approx-
imately 150 000 plaques were screened, from which
39 independent clones were identi¢ed as positive.
After a second screening using the 75-bp insert frag-
ment as a probe that hybridized only to sIL-4R, two
of 39 clones were positive and of the same size. Fi-
nally, two clones were selected as representative of
the soluble and membrane-bound forms. The frag-
ments were digested, subconstructed into the NotI/
SalI site of pBluescriptSK+ vector and designated
as pBSSK/RS36 and pBSSK/RM4, respectively. Be-
cause the cDNAs extended about 4 kbp in length,
several restriction enzyme sites were used (Fig. 3),
and the resulting small fragments were again sub-
cloned and sequenced. The full-length mIL-4R
cDNA (pBSSK/RM4) was 3530 bp containing the
ATG codon and a poly(A) stretch much longer
than that reported for this sequence in the rat. This
cDNA has an open reading frame encoding 801 ami-
no acids £anked by 178 bp of 5P and 943 bp of 3P
noncoding sequence. Clone pBSSK/RS36 was distin-
guished from pBSSK/RM4 by having a 75-bp inser-
tion at nucleotide number 849 containing a termina-
tion codon TGA (Figs. 2 and 3). This insertion
Fig. 3. Restriction maps and schematic representation of sIL-4R. The open box represents the transmembrane region; the shaded box
stands for insert fragments. The boxed nucleotide acid sequence shows the insertion with a termination TGA codon.
Fig. 2. Nucleotide sequences of the ampli¢ed RT^PCR prod-
ucts. The whole nucleotide sequence represents a 622-bp band
corresponding to sIL-4R message. A 75-bp message in black
box is inserted into mIL-4R with 547 bp. Six amino acids are
newly generated in this insertion. The PCR primer sites are
marked by dotted underline and the transmembrane region is
underlined.
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generated additional six amino acids. The resulting
protein was 229 amino acids in length and repre-
sented a potential soluble form of the IL-4 receptor
in rats.
3.4. Tissue distribution of sIL-4R
To de¢ne the distribution of sIL-4R in vivo, we
again conducted the RT^PCR, this time with tissues
from brain, heart, lung, liver, kidney, spleen, and
muscle by using the relevant mRNA. Recapitulating
its appearance in the kidney and spleen, sIL-4R was
also expressed in the lung and liver but not in the
brain, heart or muscle (Fig. 4).
3.5. Expression and puri¢cation of sIL-4R fusion
protein
To investigate the possible function of sIL-4R,
sIL4R-myc fusion proteins were generated. The
translation portion of sIL-4R cDNA was inserted
into a pcDNA3.1C mammalian expression vector
with the myc epitope and polyhistidine tag sequence
(Fig. 5A). Plasmids were constructed then transfected
into COS-7 cells. The resulting recombinant proteins
were puri¢ed with resin by polyhistidine tag. Subse-
quent Western blot analysis (Fig. 5B) showed that
COS-7 cells transfected with pcDNA3.1C/sIL4R se-
creted sIL-4R-myc fusion proteins with a molecular
size of about 45 kDa. Cells transfected with pcDNA
3.1LacZ also secreted LacZ-myc fusion proteins;
however, no myc fusion proteins were detectable in
cells transfected with pcDNA 3.1C vector alone.
3.6. Inhibition by sIL-4R on splenocyte proliferation
induced by IL-4
To examine the e¡ect of sIL-4R on the biological
activity of IL-4, splenocyte proliferation in response
to IL-4 stimulation was used as originally described
by Noble and Kemeny [32]. When combined with
PMA, IL-4 induced the proliferation of spleen cells
in a dose-dependent manner (Fig. 6A). When the
cells were cultured in 10 ng/ml IL-4 with incremental
increases of recombinant sIL-4R, thymidine incorpo-
ration decreased dose-dependently (Fig. 6B). In con-
trast, recombinant LacZ had no inhibitory e¡ect on
the cell proliferation induced by IL-4. In each group,
the di¡erence between outcomes with sIL-4R and
LacZ was statistically signi¢cant. Clearly, sIL-4R
neutralized the biological e¡ects of IL-4 in vitro.
4. Discussion
As documented here, we have cloned and deter-
mined the entire sequence of rat IL-4R cDNA in-
cluding sIL-4R and mIL-4R. To our knowledge,
Fig. 4. Distribution of rat sIL-4R by RT^PCR analysis. Samples were from brain (lane 1), heart (lane 2), lung (lane 3), liver (lane 4),
kidney (lane 5), spleen (lane 6), muscle (lane 7), and reagent control without a template (lane 8). The band at 622 bp corresponds to
the sIL-4R message, and the band at 547 bp stands for mIL-4R. The housekeeping gene, actin (363 bp), was also ampli¢ed as a posi-
tive control for intact RNA and e⁄ciency of RT^PCR.
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this is the ¢rst report of sIL-4R in the rat. When we
then prepared recombinant sIL-4R and studied its
e¡ect on biological activity, our results con¢rmed
that sIL-4R can neutralize IL-4-stimulated prolifera-
tion of spleen cells. After a ¢rst screening of the RT^
PCR product from rat kidney cells, 39 clones of IL-
4R cDNA were obtained. A second screening with
an RIS probe, which hybridized only to sIL-4R,
yielded two clones. Therefore sIL-4R accounts for
about 5% of IL-4R mRNA, consistent with Mosley’s
observation of 5^10% in mice [1]. At least in normal
kidneys, the expression of mIL-4R is thus preferen-
tial to that of sIL-4R, accounting for the very weak
band of sIL-4R we found after performing RT^PCR.
Fig. 6. [3H]Thymidine-incorporation assay of splenocyte proliferation. (A) Splenocytes in combination with 10 nM PMA were cultured
with increasing concentrations of rat recombinant IL-4. (B) PMA-activated splenocyte were cultured with 10 ng/ml IL-4 in the pres-
ence of various recombinant sIL-4R-myc (b) and LacZ-myc (a). Cells were cultured in triplicate for 24 h and pulsed with
[3H]thymidine. All data are expressed as means þ S.E. Statistical di¡erences were assessed by Sche¡e test in each group. Each group
showed a signi¢cant di¡erence (P6 0.001).
Fig. 5. (A) Map of the constructed rat sIL-4R expression vector (pcDNA3.1C/sIL-4R). (B) Western blot analysis of recombinant pro-
tein. Culture media from COS-7 cells transfected with pcDNA3.1C vector alone (lane 1), pcDNA3.1C/sIL-4R (lane 2) and pcDNA3.1
LacZ (lane 3) were puri¢ed by histidine-a⁄nity resin; eluted samples were subjected to SDS^PAGE followed by immunoblotting with
anti-myc monoclonal antibody and detected by ECL. Molecular mass is indicated in kDa.
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On that basis, we speculated that, under some patho-
logical conditions, the normally limited expression of
sIL-4R may be upregulated and act to restrain the
immunological injury that IL-4 can cause. IL-4 is not
the only cytokine with two forms of receptors, mem-
brane-bound and soluble. However, unlike other
soluble cytokine receptors that are formed by shed-
ding of membrane receptors, such as sIL-2R and
sTNF-R [34,35], the murine sIL-4R is transcribed
from an alternative message, quite separate from
that encoding the membrane form [1]. Murine sIL-
4R has a short insert that introduces a termination
codon upstream from the transmembrane region.
This termination site results in secretion of the recep-
tors truncated form [1]. Since the sIL-4R binds IL-4
with high a⁄nity, it can act as a neutral antagonist
of IL-4 activity, competing with the mIL-4R on tar-
get cells for the binding of IL-4. Although Richter et
al. cloned partial rat IL-4R, until now this form of
the cytokine receptor had not been found as a natu-
ral constituent of rats [30]. Furthermore, Idzerda,
who tested humans for IL-4R, concluded that only
murine species secreted IL-4R [31].
In this study, to seek sIL-4R in rats, we designed a
pair of primers spanning the extracellular and intra-
cellular domains of the IL-4R. The results of PCR
testing clearly demonstrated that rat GEC and
splenic cells express both sIL-4R and mIL-4R. Suc-
cessful cloning and subsequent sequencing of the full-
length IL-4R cDNA showed 3605 bp in sIL-4R and
3530 bp in mIL-4R. The latter fragment, mIL-4R,
was longer than the 2450 bp reported by Richter et
al. [2], perhaps because of an underestimation.
The unique di¡erence between the two forms of
rat IL-4R is the 75-bp insertion sequence in sIL-4R
at nucleotide number 849 upstream of the transmem-
brane region. In comparison to rats, mice have an
sIL-4R insertion of 114 bp [1]. However, both these
sequences contain a termination TGA codon that
introduces six novel amino acids at the C-terminus.
This ¢nding suggests that formation of the insert was
evolutionary event with biological signi¢cance.
Although sIL-4R lacks a transmembrane region
and cytoplasmic domain, it still has high a⁄nity to
IL-4. Studies done in vivo and in vitro have demon-
strated that sIL-4R can act as competitive inhibitor
of IL-4 binding to membrane receptors, thereby an-
tagonizing the cytokines biological activity. For ex-
ample, Mosley et al. found that sIL-4R speci¢cally
blocked IL-4-induced CTLL cell proliferation [1].
Similarly, by generating and using a sIL4R-myc fu-
sion protein, we found that recombinant sIL-4R in-
hibited IL-4-induced splenocyte proliferation. In
both situations, sIL-4R neutralized the biological ef-
fects of IL-4.
In the present study, cultured rat GEC expressed
large amounts of sIL-4R, and whole sIL-4R was re-
trieved after screening cDNA from a rat kidney li-
brary. Our experiments showed that the expression
of sIL-4R is much lower in whole kidney tissue than
in cultured GEC (Figs. 1 and 4), which may account
for our ¢nding only two sIL-4R clones from 39 IL-
4R clones in the present study. Furthermore, the IL-
4R in kidney tissue is mostly in the membrane form
(94.9%). Although the precise function of sIL-4R is
still conjectural, much evidence has implicated IL-4
in the pathogenesis of both human and experimental
glomerulonephritis [8^19]. We found that Jak3,
which is activated only by IL-4 in GEC, is upregu-
lated in IgA nephropathy and accompanies deterio-
rating glomerular function [10]. In addition, by using
in situ hybridization, Furusu and Miyazaki demon-
strated that the expression of IL-4 correlated posi-
tively with the degree of mesangial hypercellularity
and expansion of the extracellular matrix [19]. These
reports suggested that the expression and function of
IL-4R are critical in glomerulonephropathy. Quite
possibly, sIL4-R is expressed in the renal tissue other
than GEC; for example, the latter authors reported
that the IL-4R was expressed constantly in mesangial
cells. However, we did not detect either type of IL-
4R in cultured mesangial cells (Fig. 1), perhaps be-
cause that trait was lost during culture. Technical
improvement of in situ hybridization or antibody
reactive with sIL-4R should resolve this issue.
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